Cargando…
Using thrombocytopenia modeling to investigate the mechanisms underlying platelet depletion induced by pan‐proteasome inhibitors
Pan‐proteasome inhibitors (pPIs) significantly improve outcomes in patients with multiple myeloma; however, their indiscriminate inhibition of multiple proteasome and immunoproteasome subunits causes diverse toxicities, including thrombocytopenia. We investigated the mechanisms underlying the platel...
Autores principales: | Lignet, Floriane, Becker, Andreas D., Gimmi, Claude, Rohdich, Felix, El Bawab, Samer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124357/ https://www.ncbi.nlm.nih.gov/pubmed/34845847 http://dx.doi.org/10.1002/psp4.12743 |
Ejemplares similares
-
A First-in-human, Dose-escalation Study of the Methionine Aminopeptidase 2 Inhibitor M8891 in Patients with Advanced Solid Tumors
por: Carducci, Michael A., et al.
Publicado: (2023) -
Modeling long-term tumor growth and kill after combinations of radiation and radiosensitizing agents
por: Cardilin, Tim, et al.
Publicado: (2019) -
Exposure-response modeling improves selection of radiation and radiosensitizer combinations
por: Cardilin, Tim, et al.
Publicado: (2021) -
Model-based assessment of combination therapies – ranking of radiosensitizing agents in oncology
por: Baaz, Marcus, et al.
Publicado: (2023) -
The Role of the Proteasome in Platelet Function
por: El-Kadiry, Abed El-Hakim, et al.
Publicado: (2021)